Teyi Pharmaceutical announced that it expects net profit of 173 million yuan to 183 million yuan in 2022, an increase of 36.31%-44.19% over the previous year. In the fourth quarter, after the epidemic was liberalized, the company increased the production and market supply of drugs for epidemic prevention and control. The company's sales of cough tablets and other related drugs increased significantly over the same period, leading to an increase in revenue while bringing good operating performance to the company.
特一药业：2022年净利同比预增36%-44%
Teyi Pharmaceutical: Net profit is expected to increase 36%-44% year-on-year in 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.